Mathai M L, Evered M D, McKinley M J
Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Victoria, Australia 3052.
Am J Physiol. 1998 Aug;275(2):R548-54. doi: 10.1152/ajpregu.1998.275.2.R548.
This study investigated the effect of intracerebroventricular administration of the angiotensin AT1 receptor antagonist losartan on the natriuresis, pressor effect, and arginine vasopressin (AVP) secretion caused by intracerebroventricular infusion of either ANG II, hypertonic saline, or carbachol. Losartan (1 mg/h) or artificial cerebrospinal fluid (CSF) was infused into the lateral ventricle before, during, and after infusions of either ANG II at 10 microg/h for 1 h, 0.75 mol/l NaCl at 50 microl/min for 20 min, or carbachol at 1.66 microg/min for 15 min. Intracerebroventricular infusions of ANG II, 0.75 mol/l NaCl, or carbachol caused increases in renal Na+ and K+ excretion, arterial pressure, and plasma AVP levels. Increases in arterial pressure, Na+ excretion, and plasma AVP concentration ([AVP]) in response to intracerebroventricular ANG II or intracerebroventricular 0.75 mol/l NaCl were either abolished or attenuated by intracerebroventricular infusion of losartan but not by intracerebroventricular infusion of artificial CSF or intravenous losartan. Intracerebroventricular losartan did not reduce the increase in plasma [AVP] or arterial pressure in response to intracerebroventricular carbachol, but it did attenuate the natriuretic response to intracerebroventricular carbachol. We conclude that an intracerebroventricular dose of losartan (1 mg/h) that inhibits responses to intracerebroventricular ANG II also inhibits vasopressin secretion, natriuresis, and the pressor response to intracerebroventricular hypertonic saline. These results suggest that common neural pathways are involved in the responses induced by intracerebroventricular administration of ANG II and intracerebroventricular hypertonic NaCl. We propose that intracerebroventricular infusion of hypertonic saline activates angiotensinergic pathways in the central nervous system subserving the regulation of fluid and electrolyte balance and arterial pressure in sheep.
本研究调查了脑室内注射血管紧张素AT1受体拮抗剂氯沙坦对脑室内输注血管紧张素II(ANG II)、高渗盐水或卡巴胆碱所引起的利钠作用、升压作用及精氨酸加压素(AVP)分泌的影响。在以10微克/小时的速度输注ANG II 1小时、以50微升/分钟的速度输注0.75摩尔/升氯化钠20分钟或以1.66微克/分钟的速度输注卡巴胆碱15分钟之前、期间及之后,将氯沙坦(1毫克/小时)或人工脑脊液(CSF)注入侧脑室。脑室内输注ANG II、0.75摩尔/升氯化钠或卡巴胆碱可导致肾钠和钾排泄增加、动脉血压升高及血浆AVP水平升高。脑室内输注氯沙坦可消除或减弱对脑室内ANG II或脑室内0.75摩尔/升氯化钠的动脉血压升高、钠排泄增加及血浆AVP浓度([AVP])升高反应,但脑室内输注人工脑脊液或静脉注射氯沙坦则无此作用。脑室内氯沙坦并未降低对脑室内卡巴胆碱的血浆[AVP]升高或动脉血压升高反应,但它确实减弱了对脑室内卡巴胆碱的利钠反应。我们得出结论,抑制对脑室内ANG II反应的脑室内剂量氯沙坦(1毫克/小时)也抑制加压素分泌、利钠作用及对脑室内高渗盐水的升压反应。这些结果表明,共同的神经通路参与了脑室内注射ANG II和脑室内高渗氯化钠所诱导的反应。我们提出,脑室内输注高渗盐水激活了中枢神经系统中参与绵羊体液和电解质平衡及动脉血压调节的血管紧张素能通路。